Biolase (BIOL) to Respond to Oracle Partners' Suit in Court; Issues Statement
Tweet Send to a Friend
Biolase Technology, Inc. (Nasdaq: BIOL) issued a statement in response to a press release issued by Oracle Partners L.P. ("Oracle") ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE